Stay updated on Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.

Latest updates to the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new revision entry v3.5.3 was added to the history, replacing the previous v3.5.2 entry.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedNew history entry Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed from the study record history.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded Revision: v3.5.0 and Deleted Revision: v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page revision in the footer updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check88 days agoChange DetectedA new revision (v3.4.2) was added to the history, and an older funding notice and revision entry (v3.4.1) were removed.SummaryDifference0.6%

- Check95 days agoChange DetectedAdministrative updates: the history page shows a new funding/operating-status notice and changes the revision tag to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Arimoclomol Early Access Program in US Patients With NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol Early Access Program in US Patients With NPC Clinical Trial page.